Production (Stage)
Elanco Animal Health Incorporated
ELAN
$13.81
-$0.36-2.54%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 937.50% | -102.20% | 828.00% | -256.25% | 122.70% |
| Total Depreciation and Amortization | 29.84% | -27.06% | 4.94% | -2.41% | 41.88% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 114.29% | 94.35% | -1,039.39% | 447.37% | 0.00% |
| Change in Net Operating Assets | -523.21% | -77.42% | 1,027.27% | 112.43% | -221.23% |
| Cash from Operations | -102.26% | 9.26% | -19.00% | 9,900.00% | -98.73% |
| Capital Expenditure | -38.30% | -11.90% | -23.53% | -41.67% | 41.46% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -100.00% | -- | -100.00% | -- |
| Other Investing Activities | 71.43% | 12.50% | -900.00% | 120.00% | -183.33% |
| Cash from Investing | 35.56% | -107.23% | 3,869.70% | -189.19% | 205.71% |
| Total Debt Issued | -- | -100.00% | 191.67% | 20.00% | -- |
| Total Debt Repaid | -368.42% | 97.74% | -693.40% | -87.61% | 18.71% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -433.33% | 175.00% | -700.00% | 92.86% | -- |
| Cash from Financing | 262.50% | 97.61% | -1,340.86% | -244.44% | 80.58% |
| Foreign Exchange rate Adjustments | 137.66% | -1,062.50% | 366.67% | 84.21% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 186.36% | -129.73% | 4.23% | 1,114.29% | 58.82% |